8225 — China Health Income Statement
0.000.00%
Last trade - 00:00
- HK$131.39m
- HK$122.82m
- CNY21.43m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | HKAS | HKAS | HKAS | HKAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 63.2 | 83.1 | 83.6 | 13.1 | 21.4 |
Cost of Revenue | |||||
Gross Profit | 53.5 | 67 | 63.9 | 5.74 | 8.21 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 30.6 | 12.1 | 41.1 | 28.9 | 79.6 |
Operating Profit | 32.6 | 71 | 42.5 | -15.8 | -58.2 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 32.5 | 70.8 | 42.5 | -15.8 | -58.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 27.8 | 60.6 | 36.3 | -15.8 | -58.2 |
Net Income Before Extraordinary Items | |||||
Net Income | 27.8 | 60.6 | 36.3 | -15.8 | -58.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 27.8 | 60.6 | 36.3 | -15.8 | -58.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.028 | 0.047 | 0.039 | -0.016 | 0.001 |